[Use of prodigiozan for increasing the effectiveness of the antibiotic therapy of dysentery in children].
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004405:Dysentery, Bacillary / Q000188:drug therapy* / Q000276:immunology; D015643:Erythromycin Ethylsuccinate / Q000627:therapeutic use*; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects; D007136:Immunoglobulins / Q000032:analysis; D007223:Infant; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D011354:Prodigiozan / Q000627:therapeutic use*; D012763:Shigella flexneri; D012764:Shigella sonnei; D013997:Time Factors; D014815:Vitamins / Q000627:therapeutic use
D007136:Immunoglobulins; D011135:Polysaccharides, Bacterial; D014815:Vitamins; D015643:Erythromycin Ethylsuccinate; D011354:Prodigiozan
Ispol'zovanie prodigiozana dlia povysheniia éffektivnosti antibiotikoterapii pri dizenterii u deteĭ.